Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBRIEF COMMUNICATION

18F-FDG PET/CT Staging of Head and Neck Cancer: Interobserver Agreement and Accuracy—Results from Multicenter ACRIN 6685 Clinical Trial

Rathan M. Subramaniam, Fenghai M. Duan, Justin Romanoff, Jian Qin Yu, Twyla Bartel, Farrokh Dehdashti, Charles M. Intenzo, Lilja Solnes, JoRean Sicks, Brendan C. Stack and Val J. Lowe
Journal of Nuclear Medicine December 2022, 63 (12) 1887-1890; DOI: https://doi.org/10.2967/jnumed.122.263902
Rathan M. Subramaniam
1Otago Medical School, University of Otago, Otago, Dunedin, New Zealand;
2Duke University, Durham, North Carolina;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fenghai M. Duan
3School of Public Health, Brown University, Providence, Rhode Island;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justin Romanoff
3School of Public Health, Brown University, Providence, Rhode Island;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jian Qin Yu
4Fox Chase Cancer Center, Philadelphia, Pennsylvania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Twyla Bartel
5Global Advanced Imaging, Little Rock, Arkansas;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farrokh Dehdashti
6Washington University School of Medicine, St Louis, Missouri;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles M. Intenzo
7Thomas Jefferson University, Philadelphia, Pennsylvania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lilja Solnes
8Johns Hopkins School of Medicine, Baltimore, Maryland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JoRean Sicks
3School of Public Health, Brown University, Providence, Rhode Island;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brendan C. Stack Jr
9Southern Illinois School of Medicine, Springfield, Illinois; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Val J. Lowe
10Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    STARD flow diagram.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    ACRIN 6685 visual analysis: positive and negative neck nodes. (A and C) Negative 18F-FDG PET and 18F-FDG PET/CT findings for neck nodes, with visual analysis demonstrating 18F-FDG uptake in left level IIA lymph nodes equal to or less than 18F-FDG uptake in adjacent blood vessels. SUVmax was 1.1. (B and D) Positive 18F-FDG PET and 18F-FDG PET/CT findings for neck nodes, with visual analysis demonstrating 18F-FDG uptake in right level IIA lymph node greater than 18F-FDG uptake in adjacent blood vessels. SUVmax was 3.4.

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1.

    Diagnostic Test Statistics for Visual Assessment 18F-FDG PET/CT Scan Versus Pathology

    ReaderSensitivitySpecificityPPVNPV
    Expert H&N reader 10.791 (0.677, 0.896)0.584 (0.500, 0.665)0.417 (0.325, 0.512)0.881 (0.811, 0.942)
    Expert H&N reader 20.683 (0.547, 0.810)0.724 (0.646, 0.797)0.466 (0.352, 0.583)0.866 (0.801, 0.925)
    Central adjudicated read0.740 (0.629, 0.845)0.644 (0.567, 0.716)0.443 (0.349, 0.538)0.866 (0.800, 0.924)
    Site read0.700 (0.581, 0.817)0.699 (0.622, 0.774)0.471 (0.370, 0.580)0.859 (0.792, 0.917)
    • H&N = head and neck.

    • Data in parentheses are 95% CIs.

    • View popup
    TABLE 2.

    Diagnostic Test Statistics for the Dichotomized SUVmax Result Versus Pathology

    1.8 cutoff value for SUVmax3.5 cutoff value for SUVmax
    ReaderSensitivitySpecificityPPVNPVSensitivitySpecificityPPVNPV
    Expert H&N scan reader 10.471 (0.327, 0.623)0.894 (0.862, 0.923)0.268 (0.167, 0.381)0.954 (0.931, 0.972)0.300 (0.155, 0.459)0.965 (0.942, 0.982)0.412 (0.231, 0.611)0.944 (0.919, 0.965)
    Expert H&N scan reader 20.250 (0.109, 0.419)0.900 (0.868, 0.929)0.167 (0.070, 0.281)0.938 (0.910, 0.962)0.183 (0.062, 0.330)0.967 (0.947, 0.983)0.306 (0.116, 0.517)0.937 (0.911, 0.961)
    Combined central SUVmax0.507 (0.356, 0.652)0.851 (0.814, 0.884)0.225 (0.142, 0.315)0.953 (0.930, 0.972)0.267 (0.135, 0.412)0.970 (0.952, 0.986)0.435 (0.243, 0.634)0.939 (0.915, 0.961)
    Site read0.395 (0.250, 0.548)0.903 (0.874, 0.930)0.263 (0.154, 0.383)0.945 (0.920, 0.966)0.250 (0.119, 0.395)0.972 (0.955, 0.987)0.442 (0.235, 0.658)0.937 (0.912, 0.959)
    • H&N = head and neck.

    • Data in parentheses are 95% CIs.

Additional Files

  • Figures
  • Tables
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 63 (12)
Journal of Nuclear Medicine
Vol. 63, Issue 12
December 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-FDG PET/CT Staging of Head and Neck Cancer: Interobserver Agreement and Accuracy—Results from Multicenter ACRIN 6685 Clinical Trial
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F-FDG PET/CT Staging of Head and Neck Cancer: Interobserver Agreement and Accuracy—Results from Multicenter ACRIN 6685 Clinical Trial
Rathan M. Subramaniam, Fenghai M. Duan, Justin Romanoff, Jian Qin Yu, Twyla Bartel, Farrokh Dehdashti, Charles M. Intenzo, Lilja Solnes, JoRean Sicks, Brendan C. Stack, Val J. Lowe
Journal of Nuclear Medicine Dec 2022, 63 (12) 1887-1890; DOI: 10.2967/jnumed.122.263902

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-FDG PET/CT Staging of Head and Neck Cancer: Interobserver Agreement and Accuracy—Results from Multicenter ACRIN 6685 Clinical Trial
Rathan M. Subramaniam, Fenghai M. Duan, Justin Romanoff, Jian Qin Yu, Twyla Bartel, Farrokh Dehdashti, Charles M. Intenzo, Lilja Solnes, JoRean Sicks, Brendan C. Stack, Val J. Lowe
Journal of Nuclear Medicine Dec 2022, 63 (12) 1887-1890; DOI: 10.2967/jnumed.122.263902
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Measuring Total Metabolic Tumor Volume from 18F-FDG PET: A Reality Check
  • Bioanalytic Hybrid System Merging 3-Dimensional Cell Culture and Chromatographic Precision for Unprecedented Preclinical Insights in Molecular Imaging
  • Radiances of Cerenkov-Emitting Radionuclides on the In Vivo Imaging System
Show more BRIEF COMMUNICATION

Similar Articles

Keywords

  • oncology: head and neck
  • FDG PET/CT
  • head and neck cancer
  • staging
SNMMI

© 2025 SNMMI

Powered by HighWire